[A comparative study between cefminox (MT-141) and cefotaxime in respiratory tract infections].
D002439:Cefotaxime / Q000009:adverse effects / Q000627:therapeutic use*; D002513:Cephamycins / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D002513:Cephamycins; D002439:Cefotaxime; C046079:cefminox